DE10199031I2 - Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma. - Google Patents

Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma.

Info

Publication number
DE10199031I2
DE10199031I2 DE2001199031 DE10199031C DE10199031I2 DE 10199031 I2 DE10199031 I2 DE 10199031I2 DE 2001199031 DE2001199031 DE 2001199031 DE 10199031 C DE10199031 C DE 10199031C DE 10199031 I2 DE10199031 I2 DE 10199031I2
Authority
DE
Germany
Prior art keywords
allergic rhinitis
cetirizine
treatment
asthma
cetrizine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE2001199031
Other languages
English (en)
Other versions
DE10199031I1 (de
Inventor
Nancy Gray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25491375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10199031(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of DE10199031I1 publication Critical patent/DE10199031I1/de
Application granted granted Critical
Publication of DE10199031I2 publication Critical patent/DE10199031I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE2001199031 1992-09-24 1993-09-22 Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma. Active DE10199031I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95117992A 1992-09-24 1992-09-24
PCT/US1993/008991 WO1994006429A1 (en) 1992-09-24 1993-09-22 Compositions for treating allergic disorders using (-) cetirizine

Publications (2)

Publication Number Publication Date
DE10199031I1 DE10199031I1 (de) 2001-10-04
DE10199031I2 true DE10199031I2 (de) 2004-09-23

Family

ID=25491375

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69320975T Expired - Lifetime DE69320975T2 (de) 1992-09-24 1993-09-22 Verwendung von (-) Cetirizin zur Behandlung allergischer Rhinitis und und Asthma
DE2001199031 Active DE10199031I2 (de) 1992-09-24 1993-09-22 Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69320975T Expired - Lifetime DE69320975T2 (de) 1992-09-24 1993-09-22 Verwendung von (-) Cetirizin zur Behandlung allergischer Rhinitis und und Asthma

Country Status (12)

Country Link
US (1) US5698558A (de)
EP (2) EP0950412A3 (de)
JP (2) JPH08501561A (de)
AT (1) ATE170749T1 (de)
AU (2) AU4932093A (de)
CA (1) CA2145410A1 (de)
DE (2) DE69320975T2 (de)
DK (1) DK0663828T3 (de)
ES (1) ES2122042T3 (de)
LU (1) LU90898I2 (de)
NL (1) NL300085I2 (de)
WO (1) WO1994006429A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2145410A1 (en) * 1992-09-24 1994-03-31 Nancy M. Gray Compositions for treating allergic disorders using (-) cetirizine
AU5136193A (en) * 1992-09-24 1994-04-12 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
BE1011251A3 (fr) † 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
US6140337A (en) * 1997-12-23 2000-10-31 Schering Corporation Methods for the treatment of mental disorders
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
SE9802555D0 (sv) * 1998-07-16 1998-07-16 A & Science Invest Ab New pharmaceutical preparation and method
US6432961B1 (en) 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
US7405223B2 (en) * 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
WO2002067938A2 (en) * 2000-10-30 2002-09-06 Schering Corporation Treating or reducing the risk of cardiovascular disease
US7199241B1 (en) 2001-05-29 2007-04-03 Ucb, S.A. Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
US6977301B1 (en) 2001-05-29 2005-12-20 Ucb, S.A. Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
US20040053902A1 (en) * 2002-09-13 2004-03-18 Smith C. Steven Novel composition and method for treatment of upper respiratory conditions
SI1569650T1 (sl) * 2002-12-03 2008-08-31 Ucb Farchim Sa Uporaba levocetirizina za zdravljenje trdovratnega alergijskega vnetja nosne sluznice
WO2004103982A1 (en) * 2003-05-21 2004-12-02 Wockhardt Limited 2-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl]ethoxy]acetic acid monohydrochloride as anti-allergenic compound and process for its production
GB2403655A (en) * 2003-07-11 2005-01-12 Cipla Ltd Combined pharmaceutical product comprising a beta-2 adrenoreceptor agonist & an antihistamine for treatment of respiratory diseases such as asthma
WO2005041969A1 (en) * 2003-10-22 2005-05-12 Cipla Limited Pharmaceutical product comprising a beta-2 adrenergic agonist and an h1-receptor antagonist
WO2005077371A1 (en) * 2004-02-12 2005-08-25 Ucb Farchim Sa Use of levocetirizine for the preparation of a drug
JP2008531620A (ja) * 2005-03-03 2008-08-14 ユセベ ファルシム ソシエテ アノニム ピログルタミン酸塩並びにデキストロセチリジン及びレボセチリジンの合成のための中間体の光学分割におけるその使用
US20090082364A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched levocedtirizine
JP5291324B2 (ja) * 2007-11-01 2013-09-18 沢井製薬株式会社 口腔内崩壊錠
US7989623B2 (en) 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines
EP2062881B1 (de) 2007-11-21 2011-02-23 Synthon B.V. Verfahren zur Herstellung von N-(Diphenylmethyl)piperazinen
US20100145049A1 (en) * 2008-11-21 2010-06-10 Jie Zhu Process for making n-(diphenylmethyl)piperazines
WO2010107404A1 (en) 2009-03-16 2010-09-23 Mahmut Bilgic Stable pharmaceutical combinations
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US9254286B2 (en) * 2009-03-17 2016-02-09 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) * 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
TR201007652A2 (tr) 2010-09-20 2012-04-24 Bi̇lgi̇ç Mahmut Sinerjik etki.
TR201009398A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Fiziksel özellikleri geliştirilmiş tablet formülasyonları
KR20130009553A (ko) 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
KR102110304B1 (ko) 2017-06-30 2020-05-14 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법
CN117320697A (zh) 2021-10-21 2023-12-29 韩和制药株式会社 包含孟鲁司特或其药学上可接受的盐和左西替利嗪或其药学上可接受的盐的稳定性提高的薄膜包衣片剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
DE4209649C2 (de) * 1992-03-25 1998-12-24 Schloemann Siemag Ag Mehrstufiger hydraulischer Druck-Zylinder
CA2145410A1 (en) * 1992-09-24 1994-03-31 Nancy M. Gray Compositions for treating allergic disorders using (-) cetirizine
AU5136193A (en) * 1992-09-24 1994-04-12 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine

Also Published As

Publication number Publication date
AU4932093A (en) 1994-04-12
NL300085I2 (nl) 2002-06-03
US5698558A (en) 1997-12-16
EP0950412A3 (de) 2001-05-16
LU90898I2 (en) 2002-04-08
ATE170749T1 (de) 1998-09-15
EP0663828B1 (de) 1998-09-09
EP0663828A1 (de) 1995-07-26
ES2122042T3 (es) 1998-12-16
CA2145410A1 (en) 1994-03-31
JPH08501561A (ja) 1996-02-20
EP0950412A2 (de) 1999-10-20
DE10199031I1 (de) 2001-10-04
AU5934398A (en) 1998-05-21
JP2006036791A (ja) 2006-02-09
WO1994006429A1 (en) 1994-03-31
AU711212B2 (en) 1999-10-07
DE69320975D1 (de) 1998-10-15
NL300085I1 (nl) 2002-05-01
DE69320975T2 (de) 1999-05-12
DK0663828T3 (da) 1999-06-07

Similar Documents

Publication Publication Date Title
DE10199031I1 (de) Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma
DE69324025D1 (de) Transdermale Behandlung der Nesselsucht mit OPTISCH REINEM (+)-CETIRIZIN
ATE342964T1 (de) Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
ES2171543T3 (es) Composiciones administrables topicamente que contienen derivados del acido 3-benzoilfenilacetico para el tratamiento de trastornos inflamatorios oftalmicos.
DE69213814D1 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
PH24090A (en) 17beta-(cyclopropylamino)androst-5-en-3beta-ol and related compounds useful as c17020 lyase inhibitors
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
DK0379145T3 (da) Substituerede quinolincarboxylsyrer
ATE469907T1 (de) Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen
DE60129221D1 (de) Verwendung von alpha-msh und epo zur herstellung eines arzneimittels zur prophylaxe oder behandlung von durch ischämischen zuständen bewirkten krankheiten
ATE101147T1 (de) Pharmazeutisch verwendbare polymorphe modifikation von buspiron.
ES2181702T3 (es) Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño.
ATE269705T1 (de) Verwendung von optisch reinem (r)-tofizopam zur behandlung und pravention von angststörungen
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
DE60107516D1 (de) Verwendung von Pregabalin zur Asthma Behandlung
DE60213219D1 (de) Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten
DE69807586D1 (de) Verwendung eines Alkylendioxybenzolderivats zur Behandlung von zirkadianen Schlafstörungen
SV1994000023A (es) Pirroles sustituidos ref. ran 4070/90
FI851617A0 (fi) Triazolopyrimidinderivat.